Background
==========

Ca~V~1.3 voltage-gated L-type Ca^2+^ channels (LTCCs) play an important role for hearing, cardiac pacemaking and neuronal excitability. The C-terminus of Ca~V~1.3 tightly controls channel gating by an intramolecular protein interaction involving two putative α-helices (termed PCRD, DCRD), which form a C-terminal modulatory mechanism (CTM) only in full-length Ca~V~1.3 variants. In short (Ca~V~1.3~42A~ and Ca~V~1.3~43S~) Ca~V~1.3 α1 subunit splice variants CTM is absent which leads to profound changes in channel gating: activation occurs at more negative voltages and Ca^2+^-dependent inactivation (CDI) is faster.

Methods
=======

We quantified Ca~V~1.3 splice variants by qPCR analysis and transcript scanning, using different mouse tissues. To assess the physiological relevance of CTM, we generated a mutant mouse strain in which CTM function is disrupted by an HA-tag (Ca~V~1.3-DCRD^HA/HA^ mice). We used anti-HA antibodies to detect the expression of the HA-tagged full length channel by Western blot analysis.

Results
=======

The short variants Ca~V~1.3~42A~ (highest relative abundance in substantia nigra (SN) and ventral tegmental area (VTA)) and Ca~V~1.3~43S~ are both less abundant in mouse brain indicating that the full length form Ca~V~1.3~L~ comprises the most abundant form (about 50% of all transcripts). In mouse heart short transcripts are rare and Ca~V~1.3~L~ represents about 90% of all known transcripts. Ca~V~1.3-DCRD^HA/HA^ mice contain a homozygous interruption of the CTM by disrupting the DCRD helix with an HA-tag. We show that this induces \"short\" gating properties in this mutant full-length variant. Homozygous mice are viable and display no gross anatomical and functional abnormalities. Expression of the HA-tagged full-length channel could be detected in mouse whole brain membrane preparations. Heterozygous mice show no overt differences in locomotor activity during daytime.

Conclusions
===========

We have successfully generated a mouse model which will enable us to study the physiological role of CTM function *in vivo*. It mimics the (permanent) pharmacological inhibition of CTM function and will thus allow predictions about its potential as a new drug target. Furthermore, the HA-tagged α1 subunit will provide a tool to specifically determine the expression of Ca~V~1.3~L~ channels with anti-HA antibodies in mouse tissues.
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